MS Advanced Practice Providers

The NeurologyLive® multiple sclerosis (MS) Advanced Practice Providers (APPs) clinical focus page is a concentrated place for the latest information on the care and management of patients with MS, including relapsing MS and progressive MS, as well as related and demyelinating disorders such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. This page includes podcasts, videos and expert interviews, and news about the latest study and clinical trial findings, FDA actions, and clinical guideline updates.

Latest News

Gabriel Pardo, MD, FAAN
Ofatumumab Demonstrates Sustained Efficacy in Recently Diagnosed and Treatment-Naive Relapsing Multiple Sclerosis Over 6 Years

April 21st 2024

Ofatumumab showed a consistent and long-term reduction in relapse rates and MRI lesion activity in patients with recently diagnosed, treatment-naïve relapsing multiple sclerosis.

Making Improvements to Geographic Spacing, Access to Neurologists and MS Care
Making Improvements to Geographic Spacing, Access to Neurologists and MS Care

February 1st 2024

Biosimilars Enter the Multiple Sclerosis Treatment Paradigm
Biosimilars Enter the Multiple Sclerosis Treatment Paradigm

November 27th 2023

Advocacy and Empowerment: Finding Your Advocacy Community
Advocacy and Empowerment: Finding Your Advocacy Community

November 9th 2022

Advanced Practice Providers’ Perspectives on Optimal Multiple Sclerosis Management
Advanced Practice Providers’ Perspectives on Optimal Multiple Sclerosis Management

November 25th 2021

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.